Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia?

Bertz, L ; Barani, Jamal LU ; Gottsäter, Anders LU ; Nilsson, P M ; Mattiasson, Ingrid LU and Lindblad, Bengt LU (2006) In International Angiology 25(4). p.370-377
Abstract
Aim. This observational study was undertaken in order to analyse whether any differences could be detected between diabetic and non-diabetic patients with critical limb ischemia (CLI) concerning the inflammatory response. Methods. A total number of 259 consecutive patients with CLI were treated between October 2001 and January 2003. Results. Among the 259 patients, 135 (52%) had diabetes, previously known in 123, and detected during hospitalization in 12. The diabetic patients more often showed gangrene (P < 0.05) and infra-inguinal atherosclerosis (84% vs 67%, P=0.001). The patients with diabetes showed a better lipid profile (total cholesterol 4.6 vs 5 mmol/L, P=0.006 and lower LDL-cholesterol (2.7 vs 3.1 mmol/L, P=0.010) despite the... (More)
Aim. This observational study was undertaken in order to analyse whether any differences could be detected between diabetic and non-diabetic patients with critical limb ischemia (CLI) concerning the inflammatory response. Methods. A total number of 259 consecutive patients with CLI were treated between October 2001 and January 2003. Results. Among the 259 patients, 135 (52%) had diabetes, previously known in 123, and detected during hospitalization in 12. The diabetic patients more often showed gangrene (P < 0.05) and infra-inguinal atherosclerosis (84% vs 67%, P=0.001). The patients with diabetes showed a better lipid profile (total cholesterol 4.6 vs 5 mmol/L, P=0.006 and lower LDL-cholesterol (2.7 vs 3.1 mmol/L, P=0.010) despite the same frequency of statin treatment. They showed a higher creatinine (149 vs 117 pmol/L, P=0.0003) than the nondiabetic patients. Of the inflammatory markers, C-reactive protein (CRP) was equally elevated in both groups. Tumor necrosis factor-a (TNF-a) was increased among the diabetic patients (2.6 vs 1.8 pg/mL, P < 0.05), and this difference was most evident in those with gangrene. Neopterin was also higher among the diabetic patients (31 vs 21 mmol/L, P < 0.01), but CD40L was not different between groups. Conclusions. Diabetes mellitus was very common in CLI patients, and more often combined with renal impairment and infra-inguinal atherosclerosis. The inflammatory markers TNF-alpha and neopterin were elevated in patients with diabetes as compared to non-diabetic patients, but this difference cannot explain why CLI is 10 times more frequent in diabetic patients. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
keywords
limb ischemia, diabetes mellitus, inflammatory markers, neopterin, tumor necrosis factor alfa, CD40L
in
International Angiology
volume
25
issue
4
pages
370 - 377
publisher
Minerva Medica
external identifiers
  • wos:000244592700006
  • scopus:33847673520
ISSN
1827-1839
language
English
LU publication?
yes
id
a2b249a5-c2ea-43b0-ad68-d94f967e0809 (old id 164032)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17164743&dopt=Abstract
date added to LUP
2016-04-01 11:50:56
date last changed
2025-04-03 18:20:10
@article{a2b249a5-c2ea-43b0-ad68-d94f967e0809,
  abstract     = {{Aim. This observational study was undertaken in order to analyse whether any differences could be detected between diabetic and non-diabetic patients with critical limb ischemia (CLI) concerning the inflammatory response. Methods. A total number of 259 consecutive patients with CLI were treated between October 2001 and January 2003. Results. Among the 259 patients, 135 (52%) had diabetes, previously known in 123, and detected during hospitalization in 12. The diabetic patients more often showed gangrene (P &lt; 0.05) and infra-inguinal atherosclerosis (84% vs 67%, P=0.001). The patients with diabetes showed a better lipid profile (total cholesterol 4.6 vs 5 mmol/L, P=0.006 and lower LDL-cholesterol (2.7 vs 3.1 mmol/L, P=0.010) despite the same frequency of statin treatment. They showed a higher creatinine (149 vs 117 pmol/L, P=0.0003) than the nondiabetic patients. Of the inflammatory markers, C-reactive protein (CRP) was equally elevated in both groups. Tumor necrosis factor-a (TNF-a) was increased among the diabetic patients (2.6 vs 1.8 pg/mL, P &lt; 0.05), and this difference was most evident in those with gangrene. Neopterin was also higher among the diabetic patients (31 vs 21 mmol/L, P &lt; 0.01), but CD40L was not different between groups. Conclusions. Diabetes mellitus was very common in CLI patients, and more often combined with renal impairment and infra-inguinal atherosclerosis. The inflammatory markers TNF-alpha and neopterin were elevated in patients with diabetes as compared to non-diabetic patients, but this difference cannot explain why CLI is 10 times more frequent in diabetic patients.}},
  author       = {{Bertz, L and Barani, Jamal and Gottsäter, Anders and Nilsson, P M and Mattiasson, Ingrid and Lindblad, Bengt}},
  issn         = {{1827-1839}},
  keywords     = {{limb ischemia; diabetes mellitus; inflammatory markers; neopterin; tumor necrosis factor alfa; CD40L}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{370--377}},
  publisher    = {{Minerva Medica}},
  series       = {{International Angiology}},
  title        = {{Are there differences of inflammatory bio-markers between diabetic and non-diabetic patients with critical limb ischemia?}},
  url          = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17164743&dopt=Abstract}},
  volume       = {{25}},
  year         = {{2006}},
}